GLP-1 Weight Loss Results — 1, 3, 6, and 12 Months

If you’re starting semaglutide or tirzepatide — or thinking about it — one of the first questions is the obvious one: how fast will I actually lose weight?

The honest answer is that it depends on your starting weight, the medication you’re on, your dose, your nutrition, your activity level, and a fair amount of individual biology. But the clinical trial data gives a strong baseline for what to expect at each stage.

Here’s what GLP-1 weight loss results actually look like at 1, 3, 6, and 12 months — based on the STEP trials (semaglutide), the SURMOUNT trials (tirzepatide), and what physicians see in real-world practice.

---

The Big-Picture Numbers

Before we break it down month by month, here are the headline averages from the major trials:

Semaglutide 2.4mg (STEP 1 trial, 68 weeks): average weight loss of 14.9% of body weight, vs 2.4% on placebo. About one-third of participants lost 20% or more.

Tirzepatide 15mg (SURMOUNT-1 trial, 72 weeks): average weight loss of 20.9% of body weight, vs 3.1% on placebo. More than half of participants on the highest dose lost 20% or more.

For a 200-pound starting weight, that’s about 30 lb on semaglutide and 42 lb on tirzepatide as a population average — though individual results vary widely.

For a closer comparison of the two medications, see our guide on semaglutide vs. tirzepatide.

---

Month 1: Adjustment, Not Dramatic Loss

The first month is mostly about getting your body used to the medication. Standard titration starts at a very low dose (0.25mg of semaglutide weekly) and increases gradually over 16+ weeks.

What clinical trials show: roughly 2–3% of body weight lost in the first month — about 4–6 lb for a 200-lb starting weight.

What you’ll notice:

• Reduced appetite and portion sizes after the first 1–2 weeks
• “Food noise” begins to quiet for many patients
• Some GI side effects (nausea, mild fatigue, occasional constipation) — usually mild
• The scale moves slowly, then a bit faster toward the end of the month

What’s normal: small fluctuations day to day. Bloating from delayed gastric emptying. A few patients lose nothing in week 1 and then drop several pounds in weeks 3–4 as they adjust.

What’s not normal: if you’re losing more than 4 lb per week consistently early on, that’s actually too fast — talk to your physician about adjusting.

The first month is a foundation-building phase. You’re getting onto the medication, your body is recalibrating its appetite signals, and you’re learning what eating with GLP-1 looks like.

---

Month 3: The Curve Steepens

By the end of month 3, you’re typically at or near a clinically effective dose (1.0–1.7mg of semaglutide, or 5–10mg of tirzepatide). This is when the cumulative effect of consistent caloric reduction starts to show.

What clinical trials show: about 6–8% of body weight at 3 months on semaglutide; 8–11% on tirzepatide. For a 200-lb starting weight, roughly 12–22 lb total loss.

What you’ll notice:

• Clothes fitting more loosely
• Visible changes in the mirror
• Social/dining out becomes the main “hard part” — appetite is so suppressed that holiday meals or restaurant portions feel impossible
• Energy may dip if you’re not eating enough protein

What’s normal: the rate of loss usually accelerates between months 1 and 3, then begins to settle.

What’s not normal: if you’ve lost less than 3% of body weight by month 3, that may signal you need a dose adjustment or that something else is limiting your response. Talk to your physician — that’s what they’re there for.

---

Month 6: The Honeymoon Plateau

By six months, most patients are at or near their maintenance dose, and the early-phase rapid loss is behind them.

What clinical trials show: about 10–14% of body weight at 6 months on semaglutide; 14–18% on tirzepatide. For a 200-lb starting weight, that’s roughly 20–36 lb of total loss.

What you’ll notice:

• Loss continues but at a slower pace
• Some patients hit their first real plateau here
• Strength and endurance from any concurrent exercise become more apparent
• Body composition shifts — even when the scale stalls for a few weeks

What’s normal: plateaus lasting 2–4 weeks. The rate of loss shifting from “rapid” to “steady but slower.” Stable weight for a week or two doesn’t mean the medication has stopped working.

What’s not normal: an extended plateau (8+ weeks with no loss and no body composition change). This is often the moment for a dose review, a nutrition tune-up, or an evaluation of whether muscle loss is masking fat loss.

For a deeper dive on plateau strategy, our semaglutide plateau guide goes step by step.

---

Month 12: Where You Land for the Year

The 12-month mark is the most important data point in the trials, and it’s where most patients land for their first treatment year.

What clinical trials show: average weight loss of about 14.9% on semaglutide (STEP 1, 68 weeks) and about 20.9% on tirzepatide (SURMOUNT-1, 72 weeks).

What you’ll notice:

• Most of your year-one loss has happened
• Maintenance becomes the focus — keeping the new weight, not chasing further loss
• Lifestyle integration is everything (protein, strength training, sleep, social patterns)
• Some patients continue losing slowly through year 2; others maintain

What’s normal: the rate of loss has slowed substantially. The work shifts from “lose weight” to “build the habits that keep this weight off when I eventually taper or stop.”

What’s not normal: large fluctuations week to week (5+ lb swings) — usually points to inconsistency or dehydration rather than the medication itself.

---

Why Individual Results Vary So Much

The trial averages are useful, but they hide enormous variation between individuals. Two people with similar starting weights can land at very different places after a year.

The biggest factors:

Dose tolerance. Some patients reach the maximum approved dose easily; others stay at lower doses due to side effects. Higher doses generally produce more weight loss in trials.

Protein intake. Patients who hit 0.7–1.0g of protein per pound of goal body weight lose more fat and less muscle, which keeps metabolism healthier and supports long-term loss.

Strength training. Resistance exercise 2–3x weekly preserves lean mass, which is the difference between “weight loss” and “fat loss.”

Sleep and stress. Both affect cortisol, hunger hormones, and adherence. Patients who sleep 7+ hours and manage stress consistently lose more.

Starting weight. Higher starting BMI typically correlates with larger absolute weight loss in pounds, though percentage may be similar.

Concurrent conditions. Type 2 diabetes, PCOS, and some thyroid conditions can slow the rate of weight loss but don’t usually eliminate it.

Genetics. Real variation in GLP-1 receptor sensitivity and metabolic factors. Some patients are simply “high responders” or “low responders.”

---

What Doctors Actually Watch For

Beyond the scale, here’s what your physician is monitoring through the year:

• Body composition (fat mass vs. lean mass)
• Waist circumference — often improves even when scale loss slows
• Metabolic markers — A1C, fasting glucose, lipid panel, blood pressure
• Energy and mood
• Tolerance and side effect trajectory

A successful year on GLP-1 isn’t just “I lost X pounds” — it’s a fuller picture of metabolic health.

---

Diet and Lifestyle Still Matter

This deserves its own paragraph. The medication makes caloric reduction possible; it doesn’t pick what you eat with the calories you do consume. The patients with the best results almost universally:

• Prioritize protein in every meal
• Eat enough fiber and vegetables to stay regular
• Strength-train at least 2x weekly
• Sleep enough and manage stress reasonably
• Stay hydrated (slow gastric emptying makes dehydration sneakier)

Without that foundation, you can absolutely lose weight on GLP-1s — but you’ll lose more muscle, feel worse, and rebound harder if you ever stop the medication.

---

A Realistic Year-One Projection

For a typical 200-lb adult starting compounded semaglutide:

• Month 1: down 4–8 lb
• Month 3: down 14–22 lb total
• Month 6: down 22–32 lb total
• Month 12: down 28–35 lb total (semaglutide) or 35–45 lb (tirzepatide)

Your number can land anywhere in that range — or above or below — depending on the factors above. The clinical-trial averages are real, but they’re averages.

---

The Bottom Line

GLP-1 weight loss isn’t linear, and it isn’t instant. The first month is mostly setup. Months 2–6 are the steepest part of the curve. By month 12, most of your year-one loss has happened, and the work shifts to maintenance.

The medication does its job consistently; the variability you see between individuals comes from dose, protein, training, sleep, and biology. Patients who take the lifestyle pieces seriously land at the higher end of the trial averages.

---

Ready to Start Your GLP-1 Journey?

REMEVi gives you full bilingual access to licensed U.S. physicians who manage your treatment, dose adjustments, and progress through the year. Compounded semaglutide starts at $199/month, all-inclusive — physician care, medication, supplies, and shipping.

The intake form takes 5 minutes. A licensed physician reviews your file within 24 hours.

Get started with REMEVi →

---

This article is for informational purposes only and does not constitute medical advice. Individual results vary; consult with a licensed physician about realistic expectations for your situation.